Ondine Biomedical Inc Common Share (OBI)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
9.00p
Buy
9.50p
-0.25p (-2.70%)
Ondine Biomedical Inc. is dedicated to the development of non-antibiotic anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections.
Prices updated at 04 Apr 2025, 13:15 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
02 Apr 202528 Mar 202519 Mar 202517 Mar 202514 Mar 202526 Feb 202526 Feb 202519 Feb 202506 Feb 202504 Feb 2025
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Sep 2025 |
| Annual general meeting | Jun 2025 |
| Final results | Jun 2025 |
| Annual report | Jun 2025 |
| Previous date | |
|---|---|
| Half yearly results | Sep 2024 |
| Annual general meeting | Jun 2024 |
| Final results | Jun 2024 |
| Annual report | Jun 2024 |
Company reports
31 Dec 2022
Annual Report 30 Jun 2011
Quarterly Report 